Skip to content

VHCP Management III, LLC

Follow

13F filer, CIK 1738053, New York, NY

VHCP Management III, LLC reported $171,541,000 across 16 holdings for the quarter ended 2019-03-31, in a 13F-HR filed 2019-05-14. Its ten largest share positions make up 92.24% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-19-004908

Period
2019-03-31
Reported value
$172M
Holdings
16
Top 10 weight
92.24%
New
2
Sold out
1

Stakes and trades reported after 2019-03-31

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • OKUR ONKURE THERAPEUTICS INC: 13G 2,309,559 shares, 5.7% of the class, 13G filed 2026-11-20, 0001231919-26-001621Timeline
    Accepted , ingested
  • ENTX ENTERA BIO LTD: 13G 8,861,763 shares, 5.1% of the class, 13G filed 2026-10-30, 0001738048-26-000079Timeline
    Accepted , ingested
  • LYCA LYCIA THERAPEUTICS INC: 13G 6,850,237 shares, 11.9% of the class, 13G filed 2026-10-30, 0001738048-26-000077Timeline
    Accepted , ingested
  • FLSC FRAZIER LIFE SCIENCES ACQ-A: 13G 700,000 shares, 9% of the class, 13G filed 2026-10-27, 0001738048-26-000075Timeline
    Accepted , ingested
  • XFOR X4 PHARMACEUTICALS INC: 13G/A 7,644,072 shares, 7.6% of the class, 13G/A filed 2026-11-16, 0001738048-26-000100Timeline
    Accepted , ingested
  • VOR VOR BIOPHARMA INC: 13G/A 6,443,619 shares, 9.9% of the class, 13G/A filed 2026-11-16, 0001738048-26-000098Timeline
    Accepted , ingested
  • KRRO KORRO BIO INC: 13G/A 1,474,162 shares, 9.9% of the class, 13G/A filed 2026-11-16, 0001738048-26-000096Timeline
    Accepted , ingested
  • JBIO JADE BIOSCIENCES INC: 13G/A 3,858,984 shares, 5.9% of the class, 13G/A filed 2026-11-16, 0001738048-26-000094Timeline
    Accepted , ingested
  • HELP HELUS PHARMA INC: 13G/A 2,688,175 shares, 3.5% of the class, 13G/A filed 2026-11-16, 0001738048-26-000092Timeline
    Accepted , ingested
  • CBIO CRESCENT BIOPHARMA INC.: 13G/A 2,228,641 shares, 5.9% of the class, 13G/A filed 2026-11-16, 0001738048-26-000090Timeline
    Accepted , ingested
  • ACHV ACHIEVE LIFE SCIENCE INC: 13G/A 5,502,064 shares, 5.2% of the class, 13G/A filed 2026-11-16, 0001738048-26-000088Timeline
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
AXSMnew+1,068,044$15.2M
LA JOLLA PHARMACEUTICAL COnew+1,003,600$6.45M
PTGXadded+386,147$4.85M
BELLEROPHON THERAPEUTICS INCadded+142,857$93.3K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
KALVreduced-314,301-$9M
ORCHARD THERAPEUTICS PLCreduced-230,485-$4.12M
DBV TECHNOLOGIES S Aexited-636,800-$4.09M
KADMON HOLDINGS INCreduced-1,000,698-$2.64M
YUMANITY THERAPEUTICS INCreduced-125,720-$158K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2019

Share positions as resolved from 13F-HR 0000950123-19-004908, largest first. % of portfolio is the value over $171,541,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 1,284,931 shares; 2018Q4: 1,284,931 shares; 2019Q1: 970,630 shares 970,630$27.8M16.19%-314,301Timeline
TRICIDA INCTRICIDA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 650,585 shares; 2018Q4: 650,585 shares; 2019Q1: 650,585 shares 650,585$25.1M14.65%0
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 3,061,091 shares; 2018Q4: 3,061,091 shares; 2019Q1: 3,061,091 shares 3,061,091$24.9M14.53%0Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: 1,068,044 shares 1,068,044$15.2M8.86%newTimeline
ObsEva SAObsEva SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 1,159,789 shares; 2018Q4: 1,159,789 shares; 2019Q1: 1,159,789 shares 1,159,789$14.8M8.65%0
ORCHARD THERAPEUTICS PLCORCHARD THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: 1,041,515 shares; 2019Q1: 811,030 shares 811,030$14.5M8.45%-230,485
RA PHARMACEUTICALS INCRA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: 594,713 shares; 2019Q1: 594,713 shares 594,713$13.3M7.77%0
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: 423,176 shares; 2019Q1: 809,323 shares 809,323$10.2M5.93%+386,147Timeline
LA JOLLA PHARMACEUTICAL COLA JOLLA PHARMACEUTICAL COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: 1,003,600 shares 1,003,600$6.45M3.76%new
KINIKSA PHARMACEUTICALS LTDKINIKSA PHARMACEUTICALS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 327,777 shares; 2018Q4: 327,777 shares; 2019Q1: 327,777 shares 327,777$5.92M3.45%0
MARINUS PHARMACEUTICALS INCMARINUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 672,271 shares; 2018Q4: 1,258,964 shares; 2019Q1: 1,258,964 shares 1,258,964$5.26M3.07%0
KADMON HOLDINGS INCKADMON HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 2,388,572 shares; 2018Q4: 2,388,572 shares; 2019Q1: 1,387,874 shares 1,387,874$3.66M2.14%-1,000,698
BELLEROPHON THERAPEUTICS INCBELLEROPHON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 2,274,370 shares; 2018Q4: 2,274,370 shares; 2019Q1: 2,417,227 shares 2,417,227$1.58M0.92%+142,857
GEMPHIRE THERAPEUTICS INCGEMPHIRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 869,538 shares; 2018Q4: 869,538 shares; 2019Q1: 869,538 shares 869,538$1M0.58%0
YUMANITY THERAPEUTICS INCYUMANITY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: 848,610 shares; 2019Q1: 722,890 shares 722,890$911K0.53%-125,720
CONSTELLATION PHARMACEUTICALCONSTELLATION PHARMACEUTICALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 66,667 shares; 2018Q4: 66,667 shares; 2019Q1: 66,667 shares 66,667$903K0.53%0

Sold out in Q1 2019

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
DBV TECHNOLOGIES S ADBV TECHNOLOGIES S A636,800$4.09Mshares

How Q1 2019 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-19-004908 base2019-05-14acceptance time not in the bulk data set